PA
PAVM
PAVmed Inc.
$6.13
+0.41%
$44.4M
No data for this timeframe.
Vol
Market Cap$44.4M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (88%)
SEC Reports2
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001624326·Prev Close $6.10
Recent Activity
May 15, 2026
SEC
PAVmed reported Q1 2026 revenue of $22K (up from $8K YoY) but GAAP net loss attributable to common stockholders widened
8-K — Impact 6/10
May 14, 2026
earnings_calendar
PAVM Q1 2026 Earnings Scheduled — 2026-05-14
Apr 21, 2026
SEC
PAVmed Inc. has filed an S-3 shelf registration to register 9,230,786 shares of common stock for resale by selling stock
S-3 — Impact 4/10
Apr 2, 2026
Insider
Lee Victoria Tou-ho sold 70,000 shares
Chief Medical Officer @ $0.00 ($0.00)
Apr 2, 2026
Insider
O'Neil Shaun sold 110,000 shares
Chief Operating Officer @ $0.00 ($0.00)
Apr 2, 2026
Insider
Agrawal Sundeep sold 13,930 shares
Director @ $0.00 ($0.00)
Price Targets
$40.50
+561.2% upside
Strong Buy
Current $6.13
Low $16.00
Median $40.50
High $65.00
2 analysts
$16.00
$65.00
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| Dec 10, 2025 | Ascendiant Capital | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.69 ▲ +83.6% | $-0.69 — $-0.69 | 54% YoY | 1 |
| Next Q | $-0.69 ▲ +83.6% | $-0.69 — $-0.69 | -15% YoY | 1 |
| Current FY | $-2.74 ▲ +84.0% | $-2.74 — $-2.74 | 42% YoY | 1 |
| Next FY | $-2.74 | $-2.74 — $-2.74 | 0% YoY | 1 |
Latest Reports
BEARISH
8-K
6/10
PAVmed reported Q1 2026 revenue of $22K (up from $8K YoY) but GAAP net loss attributable to common stockholders widened
May 15, 2026
NEUTRAL
S-3
4/10
PAVmed Inc. has filed an S-3 shelf registration to register 9,230,786 shares of common stock for resale by selling stock
Apr 21, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 2, 2026 | Lee Victoria | A | $0.00 |
| Apr 2, 2026 | O'Neil Shaun | A | $0.00 |
| Apr 2, 2026 | Agrawal Sundeep | A | $0.00 |
| Apr 2, 2026 | Gordon Michael | A | $0.00 |
| Apr 2, 2026 | Sparks Ronald | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
10 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Lee Victoria Tou-ho | Chief Medical Officer | A | 70,000 | $0.00 | $0.00 |
| Apr 2, 2026 | O'Neil Shaun | Chief Operating Officer | A | 110,000 | $0.00 | $0.00 |
| Apr 2, 2026 | Agrawal Sundeep | Director | A | 13,930 | $0.00 | $0.00 |
| Apr 2, 2026 | Gordon Michael Adam | General Counsel | A | 110,000 | $0.00 | $0.00 |
| Apr 2, 2026 | Sparks Ronald M | Director | A | 13,930 | $0.00 | $0.00 |
| Apr 2, 2026 | White Debra | Director | A | 13,930 | $0.00 | $0.00 |
| Apr 2, 2026 | Baxter Timothy E | Director | A | 13,930 | $0.00 | $0.00 |
| Apr 2, 2026 | Glennon Michael J | Director | A | 13,930 | $0.00 | $0.00 |
| Apr 2, 2026 | MCGRATH DENNIS M | President and CFO | A | 180,000 | $0.00 | $0.00 |
| Apr 2, 2026 | Aklog Lishan | Chairman and CEO | A | 350,000 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$40.50 mean target
+561.2% upside
Strong Buy (1.50)
$16.00 Low
$65.00 High
| Metric | Value |
|---|---|
| Current Price | $6.13 |
| Target Low | $16.00 |
| Target Mean | $40.50 |
| Target Median | $40.50 |
| Target High | $65.00 |
| # Analysts | 2 |
| Recommendation | Strong Buy (1.50) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.69 | $-0.69 | $-0.69 | 54.0% | +83.6% | 1↑ 0↓ | $0.0B | 1500.0% | 1 |
| Next Q 2026-09-30 |
$-0.69 | $-0.69 | $-0.69 | -15.0% | +83.6% | 1↑ 0↓ | $0.0B | 2780.0% | 1 |
| Current FY 2026-12-31 |
$-2.74 | $-2.74 | $-2.74 | 41.6% | +84.0% | 1↑ 0↓ | $0.0B | 576.1% | 1 |
| Next FY 2027-12-31 |
$-2.74 | $-2.74 | $-2.74 | 0.0% | — | — | $0.0B | 35.9% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.690 | |
| 7d ago | $-4.200 | +3.510 |
| 30d ago | $-4.200 | +3.510 |
| 60d ago | $-4.200 | +3.510 |
| 90d ago | $-4.200 | +3.510 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| Dec 10, 2025 | Ascendiant Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 14, 2026
earnings_calendar
PAVM Q1 2026 Earnings Scheduled — 2026-05-14
Mar 23, 2026
earnings_calendar
PAVM Q4 2025 Earnings After Market Close — 2026-03-23